Healthcare
Wednesday, December 14, 2016
UPDATE 4-Actelion talking to Sanofi after J&J exit - sources
* Actelion CEO seen as stumbling block
(Recasts, adds share drop, analyst and investor comments)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment